Innovation Pharmaceuticals Inc (IPIX)

[roiresearch]

The company told us what to expect once rbl testing is complete:

"Should laboratory tests support Brilacidin’s antiviral activity against SARS-CoV-2 (COVID-19), and potentially other RNA viruses, the Company will look to expedite research and clinical development of Brilacidin as a potential antiviral therapy via pharmaceutical partnerships, academic collaborations and government grants."
Taken from Feb 24 PR

Preclinical testing will be completed within 2 weeks. So far from the prs its safe to say that tests support brilacidin's antiviral activity against covid 19.